Chloroperoxidase-catalyzed degradation of pharmaceutical pollutants in wastewater

US9938176B1 · US · B1

Patent metadata
FieldValue
Publication numberUS-9938176-B1
Application numberUS-201715609452-A
CountryUS
Kind codeB1
Filing dateMay 31, 2017
Priority dateMay 31, 2017
Publication dateApr 10, 2018
Grant dateApr 10, 2018

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention provides efficient, economical, and environmentally-friendly compositions and methods for removing pollutants from water sources. In particular embodiments, the present invention provides compositions and methods for catalyzing the degradation of pharmaceutical pollutants in wastewater using the enzyme chloroperoxidase (CPO). Another embodiment provides a method of degrading pollutants in wastewater and other water sources. In specific embodiments, the claimed composition and method can be used to degrade pharmaceutical pollutants selected from the group consisting of: acetaminophen, carbamazepine, sulfamethazine, diclofenac, and naproxen.

First claim

Opening claim text (preview).

We claim: 1. A method for degrading one or more pharmaceutical pollutants in wastewater or another source of water having pharmaceutical pollutants therein, the method comprising: administering to the polluted wastewater or water source a composition comprising about 0.5 nM to about 50 nM chloroperoxidase and remedially-effective amounts of an oxidant and a halogen ion; allowing the composition to catalyze degradation of the one or more pharmaceutical pollutants within the wastewater or water source; and allowing the one or more pharmaceutical pollutants to become sufficiently degraded. 2. The method of claim 1 , wherein the one or more pharmaceutical pollutants are degraded completely. 3. The method of claim 1 , wherein the one or more pharmaceutical pollutants are sufficiently degraded in 24 hours or less. 4. The method of claim 1 , wherein the pharmaceutical pollutants are compounds selected from acetaminophen, carbamazepine, sulfamethazine, diclofenac and naproxen. 5. The method of claim 1 , wherein, after said pharmaceutical pollutants have been allowed to degrade, the method further comprises the step of testing the wastewater or water source for the presence of metabolites and/or products of the pharmaceutical pollutants using UV-visible spectrophotometry, liquid chromatography, mass spectrometry or a combination thereof. 6. The method of claim 1 , wherein the method is carried out at a pH of about 2.0 to about 5.0. 7. The method of claim 1 , wherein the method is carried out in combination with a secondary wastewater treatment method selected from biological treatments, activated sludge, and UV treatment. 8. The method of claim 1 , wherein the chloroperoxidase is present at a concentration of about 0.5 nM to about 5.0 nM. 9. The method of claim 1 , wherein the oxidant is hydrogen peroxide. 10. The method of claim 1 , wherein the oxidant is present at a concentration ranging from about 0.03 mM to about 2.0 mM. 11. The method of claim 10 , wherein the oxidant is present at a concentration of about 0.3 mM to about 0.5 mM. 12. The method of claim 1 , wherein the halogen ion is chloride or bromide. 13. The method of claim 12 , wherein the halogen ion is chloride. 14. The method of claim 1 , wherein the halogen ion is in the form of a halide salt. 15. The method of claim 14 , wherein the halide salt is selected from potassium chloride and potassium bromide. 16. The method of claim 1 , wherein the halogen ion is present at a concentration of about 5.0 mM to about 25 mM. 17. The method of claim 16 , wherein the halogen ion is present at a concentration of about 20 mM. 18. A method for degrading one or more of the pollutants acetaminophen, carbamazepine, sulfamethazine, diclofenac and naproxen present in wastewater, or another source of water, said method comprising: administering to the wastewater or water source a composition comprising about 0.1 nM to about 5.0 nM chloroperoxidase, about 0.3 mM to about 0.5 mM hydrogen peroxide, and about 20 mM of a halogen ion; allowing the composition to catalyze degradation of the pollutants within the wastewater or water source; and allowing the pollutants to become sufficiently degraded.

Assignees

Inventors

Classifications

  • by means of halogens other than chlorine or of halogenated compounds containing halogen other than chlorine · CPC title

  • by catalytic oxidation · CPC title

  • containing sulfur · CPC title

  • containing halogen · CPC title

  • C02F3/342Primary

    characterised by the enzymes used · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9938176B1 cover?
The present invention provides efficient, economical, and environmentally-friendly compositions and methods for removing pollutants from water sources. In particular embodiments, the present invention provides compositions and methods for catalyzing the degradation of pharmaceutical pollutants in wastewater using the enzyme chloroperoxidase (CPO). Another embodiment provides a method of degradi…
Who is the assignee on this patent?
Wang Xiaotang, He Qinghao, The Florida International Univ Board Of Trustees
What technology area does this patent fall under?
Primary CPC classification C02F3/342. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Apr 10 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (B1). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).